The reduction in fasting blood glucose level ranged from 12.3 % ( P < 0.05 ) to 42 % ( P < 0.001 ) after 18 month of therapy whereas in postprandial blood glucose , the decrease ranged from 28 % ( P < 0.05 ) to 32 % ( P < 0.05 ) after 18 month of therapy .